Sustained Release Excipients Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Sustained Release Excipients Market is segmented by Product Type (Gelatin, Polymers, Minerals, Sugars, Others), Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, Others), Technology (Targeted Delivery, Microencapsulation, Wurster Technique, Others), and Geography

Sustained Release Excipients Market Snapshot

Sustained Release Excipients Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Sustained Release Excipients market studied is anticipated to grow with a CAGR of nearly 7.1%, during the forecast period.

Certain factors that are driving the market growth include increased benefits over conventional dosage forms and antibiotic resistance.

One of the major challenges for marketers of pharmaceutical products is the compliance of the patient. When a drug needs to be administered several times a day, patients' acceptance of the medication can decrease considerably, leaving the risk of insufficient treatment. A common solution to increase medication acceptance in this case is to formulate the drug in a dosage form that releases the active ingredient steadily over an extended period of time.

Sustained-release profiles allow tailored dosing of the active ingredient over an extended period of time up to 24 hours. Common ways to achieve such release rates are the use of film coating, a sustained release matrix or sustained-release drug-loaded granules.

Such sustained release formulations have gained considerable traction in the pharmaceutical industry, and will continue to be a major tool to improve the patients experience for existing and new drugs. It also represents an attractive opportunity for companies and formulators in particular to differentiate their potentially generic product from standard instant release versions in the market.

Scope of the Report

Sustained-release dosage forms are dosage forms designed to release (liberate) a drug at a predetermined rate in order to maintain a constant drug concentration for a specific period of time with minimum side effects. This can be achieved through a variety of formulations, including liposomes and drug-polymer conjugates (an example being hydrogels).

By Product Type
Gelatin
Polymers
Minerals
Sugars
Others
By Route of Administration
Oral
Intramuscular
Subcutaneous
Transdermal
Intravenous
Others
By Technology
Targeted Delivery
Microencapsulation
Wurster Technique
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral Route of Administration Holds Significant Market Share in the Global Sustained Release Excipients Market

Among the various routes of drug delivery oral route is the most preferred route. The conventional dosage form offers a few limitations which could be resolved by modifying the existing dosage form. Sustained and controlled drug delivery system helps in the maintenance of constant plasma drug concentration and retards the release rate of drug thereby extending the duration of action.

Matrix tablet is defined as an “Oral solid dosage form in which active pharmaceutical ingredient is uniformly dispersed throughout polymeric matrices (hydrophilic or hydrophobic) which retards the drug release rate.

This approach is widely used for formulating the sustained release tablets. The mechanism involved in the drug release is either dissolution controlled or diffusion controlled.

Sustained Release Excipients Market

North America Dominates the Global Sustained Release Excipients Market

North America is expected to hold a major share for the sustained release excipients market and is expected to show a similar trend over the forecast period. The US extended release excipients industry is expected to evolve significantly, along with the progress of the pharmaceutical industry, as new active pharmaceutical ingredients are developed and novel technologies are adopted (i.e., novel drug delivery systems).

Following this trend, innovative multifunctional excipients and specialty blends can be expected to arrive in the market during the forecast period. In the United States, at the macro-level, the rising global demand for pharmaceuticals has fueled the growth of drug production, and consequently, excipients consumption.

Sustained Release Excipients Market

Competitive Landscape

The global Sustained Release Excipients market is competitive and consists of a few major players. Companies like Allergan plc, AstraZeneca, GlaxoSmithKline plc, Mayne Pharma Group Limited, Mylan N.V., Novartis AG, Pfizer, Inc., Salix Pharmaceuticals, Sun Pharmaceutical Industries Ltd., among others, hold the substantial market share in the market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased benefits over conventional dosage forms

      2. 4.2.2 Antibiotic resistance

    3. 4.3 Market Restraints

      1. 4.3.1 Drug toxicity due to dose dumping

      2. 4.3.2 Need for high dose of API

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Gelatin

      2. 5.1.2 Polymers

      3. 5.1.3 Minerals

      4. 5.1.4 Sugars

      5. 5.1.5 Others

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Intramuscular

      3. 5.2.3 Subcutaneous

      4. 5.2.4 Transdermal

      5. 5.2.5 Intravenous

      6. 5.2.6 Others

    3. 5.3 By Technology

      1. 5.3.1 Targeted Delivery

      2. 5.3.2 Microencapsulation

      3. 5.3.3 Wurster Technique

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan plc

      2. 6.1.2 AstraZeneca

      3. 6.1.3 GlaxoSmithKline plc

      4. 6.1.4 Mayne Pharma Group Limited

      5. 6.1.5 Mylan N.V.

      6. 6.1.6 Novartis AG

      7. 6.1.7 Pfizer, Inc.

      8. 6.1.8 Salix Pharmaceuticals

      9. 6.1.9 Sun Pharmaceutical Industries Ltd.

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Sustained Release Excipients Market market is studied from 2018 - 2026.

The Sustained Release Excipients Market is growing at a CAGR of 7.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Mylan N.V. , Pfizer, Inc. , Sun Pharmaceutical Industries Ltd. , Salix Pharmaceuticals , Novartis AG are the major companies operating in Sustained Release Excipients Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!